SOLUtion Medical is a specialty pharmaceutical company focusing on drugs requiring mixing at the point of care. Their initial product for adrenal crisis, representing a $320M U.S. market, is a de-risked near-term revenue opportunity. Additionally, their proprietary device platform offers significant drug pipeline expansion and partner revenue upside.